HomeCompareOCLCF vs JNJ

OCLCF vs JNJ: Dividend Comparison 2026

OCLCF yields 2.20% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCLCF wins by $97.77M in total portfolio value
10 years
OCLCF
OCLCF
● Live price
2.20%
Share price
$59.90
Annual div
$1.32
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$97.80M
Annual income
$89,953,885.30
Full OCLCF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — OCLCF vs JNJ

📍 OCLCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCLCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCLCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCLCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCLCF
Annual income on $10K today (after 15% tax)
$187.18/yr
After 10yr DRIP, annual income (after tax)
$76,460,802.51/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, OCLCF beats the other by $76,456,816.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCLCF + JNJ for your $10,000?

OCLCF: 50%JNJ: 50%
100% JNJ50/50100% OCLCF
Portfolio after 10yr
$48.92M
Annual income
$44,979,287.35/yr
Blended yield
91.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OCLCF
No analyst data
Altman Z
8.8
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCLCF buys
0
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
Zoe Lofgren🏢 House$OCLCF▼ Sell$15,001 - $50,0002023-05-26
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCLCFJNJ
Forward yield2.20%2.13%
Annual dividend / share$1.32$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$97.80M$30.3K
Annual income after 10y$89,953,885.30$4,689.40
Total dividends collected$97.18M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OCLCF vs JNJ ($10,000, DRIP)

YearOCLCF PortfolioOCLCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,140$440.43$10,592$272.30+$548.00OCLCF
2$12,837$917.13$11,289$357.73+$1.5KOCLCF
3$15,711$1,975.38$12,123$472.89+$3.6KOCLCF
4$21,330$4,518.91$13,141$629.86+$8.2KOCLCF
5$34,290$11,467.23$14,408$846.81+$19.9KOCLCF
6$71,148$34,457.60$16,021$1,151.60+$55.1KOCLCF
7$209,765$133,635.89$18,122$1,588.22+$191.6KOCLCF
8$960,887$736,438.84$20,930$2,228.20+$940.0KOCLCF
9$7,333,699$6,305,549.74$24,792$3,191.91+$7.31MOCLCF
10$97,800,943$89,953,885.30$30,274$4,689.40+$97.77MOCLCF

OCLCF vs JNJ: Complete Analysis 2026

OCLCFStock

Oracle Corporation Japan engages in the development and sale of software and hardware products and solutions in Japan. The company operates through three segments: Cloud and License, Hardware Systems, and Services. It sells software solutions, such as relational database management software, middleware, and applications; hardware, including servers, storage devices, and network devices for use in building and operating IT environments, such as cloud computing environments; and cloud services through Internet and other networks, as well as provides software license update rights and technical support. The company also offers technical support, maintenance, and repair of hardware products; and consulting, customer support, and education services. In addition, it provides Oracle database, Java, Linux, and MySQL software solutions; and Oracle cloud infrastructure, which include compute, storage, networking, analysis, application development, cloud database, content management, integration, cloud marketplace and management, and governance services, as well as security, identity, and compliance solutions. Further, the company offers cloud applications, such as enterprise resource planning, enterprise performance management, supply chain and manufacturing, human capital management, and advertising and customer experience cloud application solutions, as well as NetSuite and on-premise application products and solutions; and marketing, sales, and services. It serves automotive, communications, construction and engineering, consumer goods, education and research, financial services, food and beverage, healthcare, technology, hospitality, industrial manufacturing, life sciences, media and entertainment, public sector, retail, and utilities sectors. The company was founded in 1985 and is headquartered in Tokyo, Japan. Oracle Corporation Japan is a subsidiary of Oracle Japan Holding Inc.

Full OCLCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this OCLCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCLCF vs SCHDOCLCF vs JEPIOCLCF vs OOCLCF vs KOOCLCF vs MAINOCLCF vs ABBVOCLCF vs MRKOCLCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.